rawfin.tv
DexCom G7 Shows Positive CONNECT Trial Results for Type 2 Diabetes
Top StoriesstocksAI Generated

DexCom G7 Shows Positive CONNECT Trial Results for Type 2 Diabetes

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

DexCom Inc. reported positive data from its CONNECT trial, demonstrating the effectiveness of its G7 continuous glucose monitoring system. The results showed improvements in HbA1c and time in range for adults with Type 2 diabetes not using insulin.

Medical DevicesClinical TrialsDiabetes TreatmentHealthcare Sector

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks